Samik Pharmaceutical Company LTD. (KOSDAQ:014950)
South Korea · Delayed Price · Currency is KRW 7,370.00
-160.00 (-2.12%)
At close: Oct 23, 2026
KOSDAQ:014950 Revenue
Samik Pharmaceutical Company LTD. had revenue of 15.70B KRW in the quarter ending June 30, 2026, with 5.24% growth. This brings the company's total for the last twelve months to 62.26B, up 8.69% year-over-year. In the year 2025, Samik Pharmaceutical Company LTD. had annual revenue of 60.02B with 7.45% growth. That makes Samik Pharmaceutical Company LTD. the 28,372nd largest company in the world by revenue and 1,738th in South Korea.
Revenue (ttm)
62.26B
Revenue Growth
+8.69%
P/S Ratio
1.19
Revenue / Employee
464.64M
Employees
134
Market Cap
74.20B
Revenue by Geography
- Korea 112.55B 100.0%
Fiscal year ended Dec 31, 2025 See the full KOSDAQ:014950 breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 60.02B | 4.16B | 7.45% |
| Dec 31, 2024 | 55.86B | 4.63B | 9.03% |
| Dec 31, 2023 | 51.23B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.